D-0274-2022 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0274-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 9,984 cartons.

Recall details

Product Type
Drugs
Report Date
Dec 15, 2021
Initiation Date
Nov 12, 2021
Termination Date
Jun 23, 2023
Product Quantity
9,984 cartons

Product description

Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, USP, 30 Extended-Release Tablets USP, Distributed By Walmart Inc., Bentonville, AR 72716, Product of India, NDC 49035-273-30.

Reason for recall

Failed dissolution specifications

Distribution pattern

USA Nationwide.

Code information

Lot #: AC2103329B

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0274-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0274-2022. Report a data issue: hello@regdatalab.com.